These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36769022)

  • 21. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Stevens S; Snell C; Stevens J; Keller B; VanNess JM
    Front Pediatr; 2018; 6():242. PubMed ID: 30234078
    [No Abstract]   [Full Text] [Related]  

  • 22. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Mixed Methods System for the Assessment of Post Exertional Malaise in Encephalomyelitis/Chronic Fatigue Syndrome.
    Stussman B; Calco B; Norato G; Gavin A; Chigurupati S; Nath A; Walitt B
    medRxiv; 2023 Apr; ():. PubMed ID: 37205352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC
    Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505
    [No Abstract]   [Full Text] [Related]  

  • 25. Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients.
    Glass KA; Germain A; Huang YV; Hanson MR
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological and clinical factors associated with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Ghali A; Richa P; Lacout C; Gury A; Beucher AB; Homedan C; Lavigne C; Urbanski G
    J Transl Med; 2020 Jun; 18(1):246. PubMed ID: 32571354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis.
    Wormgoor MEA; Rodenburg SC
    J Transl Med; 2021 Jan; 19(1):1. PubMed ID: 33397399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Cheng Y; Xu SM; Takenaka K; Lindner G; Curry-Hyde A; Janitz M
    Gene; 2023 Aug; 877():147568. PubMed ID: 37328077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed methods system for the assessment of post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an exploratory study.
    Stussman B; Calco B; Norato G; Gavin A; Chigurupati S; Nath A; Walitt B
    BMJ Neurol Open; 2024; 6(1):e000529. PubMed ID: 38352048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Stussman B; Williams A; Snow J; Gavin A; Scott R; Nath A; Walitt B
    Front Neurol; 2020; 11():1025. PubMed ID: 33071931
    [No Abstract]   [Full Text] [Related]  

  • 34. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
    Twisk FN
    Front Physiol; 2014; 5():109. PubMed ID: 24734022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome.
    Davenport TE; Chu L; Stevens SR; Stevens J; Snell CR; Van Ness JM
    Work; 2023; 74(4):1199-1213. PubMed ID: 36938769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
    Twisk FN; Maes M
    Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey.
    Chu L; Valencia IJ; Garvert DW; Montoya JG
    PLoS One; 2018; 13(6):e0197811. PubMed ID: 29856774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulatory effects of cognitive exertion on regional functional connectivity of the salience network in women with ME/CFS: A pilot study.
    Manca R; Khan K; Mitolo M; De Marco M; Grieveson L; Varley R; Wilkinson ID; Venneri A
    J Neurol Sci; 2021 Mar; 422():117326. PubMed ID: 33556867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Davenport TE; Lehnen M; Stevens SR; VanNess JM; Stevens J; Snell CR
    Front Pediatr; 2019; 7():82. PubMed ID: 30968005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.